Silicosis

It is an occupational pneumoconiosis caused by the inhalation of fine crystalline 'silica' (quartz) dust that penetrates the deepest alveoli. The immune system's inability to clear these particles leads to chronic inflammation and rigid, fibrotic scarring of the pulmonary tissue.

It is predominantly observed in individuals working without adequate respiratory protection in professions such as mining (coal/gold), denim sandblasting (jeans bleaching), masonry, granite and marble cutting, ceramics, glass manufacturing, and foundry work.

Pulmonary macrophages engulf the silica particles, but the silica causes the macrophages to rupture, releasing inflammatory cytokines. This recurrent cycle of phagocytosis, cellular death, and inflammation eventually replaces the elastic, spongy alveolar tissue with rigid, fibrotic nodules, severely impairing oxygen exchange.

The disease typically has an insidious onset 10-20 years post-exposure. Symptoms include a progressively worsening non-productive (dry) cough, exertional dyspnea (shortness of breath, e.g., when climbing stairs), and cyanosis of the nail beds in advanced stages.

A detailed occupational history is the most critical diagnostic clue. Definitive diagnosis is established via High-Resolution Computed Tomography (HRCT) of the chest, which typically reveals small, rounded opacities in the upper lung zones and characteristic 'eggshell' calcifications in the hilar lymph nodes.

No. There is no pharmacological treatment capable of dissolving or reversing the fibrotic scar tissue in the lungs. The primary intervention is the immediate cessation of silica exposure. Supportive management includes bronchodilators, corticosteroids, and supplemental oxygen. In end-stage respiratory failure, a lung transplant is the only viable life-saving option.